- Home
- MDGL vs TOL Comparison
MDGL vs TOL Comparison
Compare MDGL & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | TOL |
|---|---|---|
| Founded | 2011 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDGL | TOL |
|---|---|---|
| Price | $476.87 | $161.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $631.46 | $156.19 |
| AVG Volume (30 Days) | 302.4K | ★ 1.2M |
| Earning Date | 02-19-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 13.49 |
| Revenue | $740,640,000.00 | ★ $10,966,723,000.00 |
| Revenue This Year | $435.42 | N/A |
| Revenue Next Year | $54.39 | $7.86 |
| P/E Ratio | ★ N/A | $11.95 |
| Revenue Growth | ★ 864.21 | 1.11 |
| 52 Week Low | $265.00 | $86.67 |
| 52 Week High | $615.00 | $162.03 |
Technical Indicators
Market Signals| Indicator | MDGL | TOL |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 73.21 |
| Support Level | $458.00 | $142.67 |
| Resistance Level | $486.88 | $155.52 |
| Average True Range (ATR) | 19.28 | 4.89 |
| MACD | 0.70 | 1.09 |
| Stochastic Oscillator | 40.73 | 98.08 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.